Physician

Narinder Singh Bajwa, M.D.

According to 2025 Medicare claims, Narinder Bajwa, M.D. (NPI: 1750332920) practices cardiology in the Yuba City, CA market, with the plurality of this provider's patient population coming from Sutter, CA. This provider's primary affiliated billing organization is SUTTER VALLEY MEDICAL FOUNDATION (NPI: 1992939565; TIN: 680273974) and primary practice location at 95991-5071. Bajwa is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Bajwa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,586 traditional Medicare patients, billed 9,347 HCPCS/CPT codes, and received $704,082 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 7,695 prescription claims across 1,040 beneficiaries totaling $1,793,026 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 24 claims. Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $1,156,232 to $704,082. In contrast, Part D prescription costs have risen steadily, from $888,549 to $1,793,026. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $16,509 and ending at $3,872.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,222	15,932	$1,156,232
2016	2,291	15,978	$1,162,454
2017	2,142	14,878	$1,129,480
2018	2,035	12,920	$999,822
2019	1,908	9,328	$706,651
2020	1,735	5,385	$425,265
2021	1,622	6,436	$582,218
2022	1,583	6,341	$561,609
2023	1,542	5,657	$450,929
2024	1,586	9,347	$704,082

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,013	10,366	$888,549
2016	994	10,212	$1,076,035
2017	997	9,289	$1,137,802
2018	998	8,682	$1,377,824
2019	987	8,412	$1,632,794
2020	987	7,863	$1,625,119
2021	981	7,538	$1,723,291
2022	1,032	7,786	$2,021,490
2023	1,018	7,397	$1,910,785
2024	1,040	7,695	$1,793,026

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	141	$14,517
2016	N/R	143	$7,879
2017	N/R	73	$39,097
2018	N/R	21	$1,030
2019	N/R	12	$649
2020	N/R	20	$1,593
2021	N/R	12	$925
2022	N/R	24	$1,351
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,049	1,078	$149
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,365	2,703	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	258	276	$75
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	1,219	1,717	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	331	354	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	712	46,003	$881,745
Entresto	Sacubitril/Valsartan	146	9,093	$180,439
Repatha Sureclick	Evolocumab	182	8,618	$163,601
Xarelto	Rivaroxaban	114	7,800	$140,528
Jardiance	Empagliflozin	104	6,780	$128,413

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$25	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Narinder Singh Bajwa, M.D.?

Tedicare shows public-source Medicare data for Narinder Singh Bajwa, M.D. (NPI 1750332920), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Narinder Singh Bajwa, M.D. have ACO affiliation data?

Narinder Singh Bajwa, M.D. is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Narinder Singh Bajwa, M.D.?

Narinder Singh Bajwa, M.D. is linked to SUTTER VALLEY MEDICAL FOUNDATION (billing NPI 1992939565) in the available physician profile data.

Does Narinder Singh Bajwa, M.D. have Open Payments data?

Narinder Singh Bajwa, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.